Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials-论文-万方医学网

Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

导出原文传递

翻译打印收藏纠错

作者： Lan, Shao-Huan ^[1] ; Wang, Chiung-Kai ^[2] ; Chang, Shen-Peng ^[3] ; Lu, Li-Chin ^[4] ; Hung, Shun-Hsing ^[5] ; Lin, Wei-Ting ^[6]

作者单位： Sch Pharmaceut Sci & Med Technol,Putian Univ ^[1] Dept Internal Med,Kaohsiung Vet Gen Hosp ^[2] Yijia Pharm ^[3] Sch Management,Putian Univ ^[4] Dept Surg,Chi Mei Hosp ^[5] Dept Orthoped,Chi Mei Med Ctr ^[6]

关键词 COVID-19 Janus kinase inhibitor mortality SARS-CoV-2 DISEASE 2019 COVID-19 EFFICACY SAFETY BLIND

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

相似文献

相关期刊

检索历史清除